Mr. Brent Ashton reports

COVALON ANNOUNCES CONFERENCE CALL TO DISCUSS FOURTH QUARTER AND YEAR END FISCAL 2025 FINANCIAL RESULTS

Covalon Technologies Ltd. will release its Q4 and year-end fiscal 2025 financial results on Thursday, Dec. 11, 2025, before markets open. A conference call and webcast to discuss the financial results will be held on Thursday, Dec. 11, 2025, at 8:30 a.m. ET.

To listen and participate through the conference call, please dial the following numbers.

North American toll-free:  1-800-549-8228

Local (Toronto):   289-819-1520

Local (New York):  646-564-2877

Conference ID:  57487

Participants will be able to ask questions of company management during the question-and-answer portion of the conference call either by asking them on the call or by submitting them using the chat function on the webcast.

A recording of the call will be available on Covalon's website under News & Events on the investors tab.

Copies of Covalon's financial statements and MD&A (management discussion and analysis) can be obtained on SEDAR+ and under SEDAR Filings on the investors tab of Covalon's website.

About Covalon Technologies Ltd.

Covalon is a leading medtech (medical technology) company dedicated to improving patient outcomes through innovative and compassionate medical products and technologies. The company's expertise spans advanced wound care, vascular access and surgical consumables, with a strong focus on enhancing healing, reducing health-care-associated infections (HAIs) and protecting skin integrity. The company's solutions are designed for patients and made for care providers. The company is listed on the TSX Venture Exchange (symbol: COV) and trades on the OTCQX market (symbol: CVALF).

We seek Safe Harbor.